Suntrust Banks’s Cantel Medical Corporation CMD Stock Holding History

Suntrust Banks’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,427	Closed	-$345K	–	1647
2016 Q3	$345K	Sell	4,427 -1,522	-26%	-$110K	﹤0.01%	1132
2016 Q2	$408K	Buy	5,949 +311	+6%	+$21.5K	﹤0.01%	1034
2016 Q1	$402K	Buy	5,638 +200	+4%	+$12.6K	﹤0.01%	1005
2015 Q4	$337K	Buy	+5,438	New	+$332K	﹤0.01%	1078

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Suntrust Banks's CMD Position: Q4 2016 in Review

Suntrust Banks sold out of Cantel Medical Corporation (CMD) in Q4 2016, closing a stake of 4,427 shares — an estimated $345K sold.

Suntrust Banks first reported a position in CMD in Q4 2015 and held it in 4 quarters. The position peaked at $408K in Q2 2016. 234 funds tracked by Wall St. Rank hold CMD as of Q4 2016.

Suntrust Banks reported no remaining Cantel Medical Corporation position as of Q4 2016 after selling out during the quarter.
Suntrust Banks sold 4,427 Cantel Medical Corporation shares in Q4 2016, an estimated $345K.
Suntrust Banks first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 4 quarters.
Suntrust Banks's Cantel Medical Corporation position peaked at $408K in Q2 2016.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2016.

Based on Suntrust Banks's 13F filing for Q4 2016, filed 9 Feb 2017.